{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:18:07Z","timestamp":1792793887739,"version":"4.5.0"},"reference-count":126,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Non-alcoholic steatohepatitis (NASH) is characterized by increased production of proinflammatory cytokines, fibrosis, and hepatocyte apoptosis. This study aimed to assess the efficacy of N-acetyl cysteine (NAC), rosuvastatin (RSV), and vitamin E (VE) in patients with NASH. Methods: A double-blinded, parallel, randomized, controlled study was conducted and registered on clinicaltrials.gov (Identifier: NCT06105060), involving 135 NASH participants, who were divided into three groups: the control group (group 1), consisting of patients receiving standard therapy VE at a dosage of 400 IU twice daily. In the treated group (group 2), patients were administered NAC at a dosage of 1200 mg twice daily, while treatment (group 3) received RSV at a dosage of 20 mg once daily. FibroScan\u00ae examination of liver tissue and fibrosis scores, along with tests for liver aminotransferases, lipid profile, glycemic parameters, and renal and hepatic functions, were assessed before and after six months of treatment. Results: The analyzed groups demonstrated a significant reduction in steatosis and lipid peroxidation (p &lt; 0.05). The NAC group demonstrated greater anti-inflammatory and anti-apoptotic effects compared to the RSV group, although this difference was not significant in the control group. NAC is conceded as the only significant antifibrotic agent in liver stiffness measurement (LSM), biological marker findings, and non-invasive liver fibrosis scores (p &lt; 0.05), in addition to its improvement of several metabolic parameters and health-related quality of life. Conclusions: Patients receiving NAC demonstrated safety and efficacy in enhancing steatosis, fibrosis, and metabolic parameters, representing a novel strategy in the management of NASH.<\/jats:p>","DOI":"10.3390\/ph18050650","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:35:13Z","timestamp":1746185713000},"page":"650","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Comparative Study of N-Acetyl Cysteine, Rosuvastatin, and Vitamin E in the Management of Patients with Non-Alcoholic Steatohepatitis: A Randomized Controlled Trial"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-0504","authenticated-orcid":false,"given":"Amr Y.","family":"Zakaria","sequence":"first","affiliation":[{"name":"Pharmacy Practice (Clinical Pharmacy) Department, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34517, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab","family":"Badawi","sequence":"additional","affiliation":[{"name":"Tropical Medicine and Infectious Diseases Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2990-5981","authenticated-orcid":false,"given":"Hasnaa","family":"Osama","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni Suef 62514, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-8090","authenticated-orcid":false,"given":"Mona A.","family":"Abdelrahman","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni Suef 62514, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5686-9416","authenticated-orcid":false,"given":"Asmaa M.","family":"El-Kalaawy","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Faculty of Medicine, Beni-Suef University, Beni Suef 62511, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_2","first-page":"8644","article-title":"Pentoxifylline and its association with kaempferol improve NASH-associated manifestation in mice through anti-apoptotic, anti-necroptotic, antioxidant, and anti-inflammatory mechanisms","volume":"26","author":"Hamouda","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100809","DOI":"10.1016\/j.neo.2022.100809","article-title":"Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis","volume":"30","author":"Petrelli","year":"2022","journal-title":"Neoplasia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e000780","DOI":"10.1136\/bmjgast-2021-000780","article-title":"Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt","volume":"8","author":"Tomah","year":"2021","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/AZMJ.AZMJ_12_20","article-title":"Value of screening for nonalcoholic fatty liver disease in hyperuricemic patients with normal body mass index by two-dimensional ultrasound: Upper Egypt experience","volume":"18","author":"Hassan","year":"2020","journal-title":"Al-Azhar Assiut Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","article-title":"Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties","volume":"79","author":"Allen","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Vancells Lujan, P., Vi\u00f1as Esmel, E., and Sacanella Meseguer, E. (2021). Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. Nutrients, 13.","DOI":"10.3390\/nu13051442"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100525","DOI":"10.1016\/j.jhepr.2022.100525","article-title":"The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes","volume":"4","author":"Younossi","year":"2022","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40265-015-0437-3","article-title":"Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway","volume":"75","author":"Filozof","year":"2015","journal-title":"Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Dabravolski, S.A., Bezsonov, E.E., Baig, M.S., Popkova, T.V., Nedosugova, L.V., Starodubova, A.V., and Orekhov, A.N. (2021). Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094459"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zelber-Sagi, S., Ivancovsky-Wajcman, D., Fliss-Isakov, N., Hahn, M., Webb, M., Shibolet, O., Kariv, R., and Tirosh, O. (2020). Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women. Antioxidants, 9.","DOI":"10.3390\/antiox9070578"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Merino de Paz, N., Quevedo-Abeledo, J.C., G\u00f3mez-Bernal, F., de Vera-Gonz\u00e1lez, A., Abreu-Gonz\u00e1lez, P., Mart\u00edn-Gonz\u00e1lez, C., Gonz\u00e1lez-Gay, M., and Ferraz-Amaro, I. (2024). Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients. J. Clin. Med., 13.","DOI":"10.3390\/jcm13030901"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Juan, C.A., P\u00e9rez de la Lastra, J.M., Plou, F.J., and P\u00e9rez-Lebe\u00f1a, E. (2021). The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094642"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yu, L., Hong, W., Lu, S., Li, Y., Guan, Y., Weng, X., and Feng, Z. (2022). The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.780496"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6489012","DOI":"10.1155\/2016\/6489012","article-title":"Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH","volume":"2016","author":"Wan","year":"2016","journal-title":"Can. J Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.32320","article-title":"NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH","volume":"76","author":"Calcagno","year":"2022","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lambrecht, J., and Tacke, F. (2020). Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.634409"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12967-022-03759-z","article-title":"Targeting HSP47 and HSP70: Promising therapeutic approaches in liver fibrosis management","volume":"20","author":"Zakaria","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"de Oliveira dos Santos, A.R., de Oliveira Zanuso, B., Miola, V.F.B., Barbalho, S.M., Santos Bueno, P.C., Flato, U.A.P., Detregiachi, C.R.P., Buchaim, D.V., Buchaim, R.L., and Tofano, R.J. (2021). Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052639"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Falamarzi, K., Malekpour, M., Tafti, M.F., Azarpira, N., Behboodi, M., and Zarei, M. (2022). The role of FGF21 and its analogs on liver associated diseases. Front. Med., 9.","DOI":"10.3389\/fmed.2022.967375"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1002\/wsbm.1499","article-title":"Liver fibrosis: Pathophysiology and clinical implications","volume":"13","author":"Berumen","year":"2021","journal-title":"WIREs Mech. Dis."},{"key":"ref_22","first-page":"736","article-title":"Collagen biology and non-invasive biomarkers of liver fibrosis","volume":"40","author":"Karsdal","year":"2020","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Shan, L., Wang, F., Zhai, D., Meng, X., Liu, J., and Lv, X. (2023). Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis. Biomed. Pharmacother., 161.","DOI":"10.1016\/j.biopha.2023.114472"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Heyens, L.J.M., Busschots, D., Koek, G.H., Robaeys, G., and Francque, S. (2021). Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front. Med., 8.","DOI":"10.3389\/fmed.2021.615978"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jtcvs.2016.01.020","article-title":"Ventricular fibrogenesis activity assessed by serum levels of procollagen type III N-terminal amino peptide during the staged Fontan procedure","volume":"151","author":"Sugimoto","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"He, L., Deng, L., Zhang, Q., Guo, J., Zhou, J., Song, W., and Yuan, F. (2017). Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. BioMed Res. Int., 2017.","DOI":"10.1155\/2017\/9729107"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10238-021-00734-8","article-title":"Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia","volume":"22","author":"Intke","year":"2022","journal-title":"Clin. Exp. Med."},{"key":"ref_28","first-page":"461","article-title":"Noninvasive biomarkers in NAFLD and NASH-current progress and future promise. Nature reviews","volume":"15","author":"Wong","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s40279-023-01918-w","article-title":"Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia","volume":"53","author":"Keating","year":"2023","journal-title":"Sports Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Li, C.-Y., Lin, W.-C., Moonmanee, T., Chan, J.P.-W., and Wang, C.-K. (2024). The Protective Role of Vitamin E against Oxidative Stress and Immunosuppression Induced by Non-Esterified Fatty Acids in Bovine Peripheral Blood Leukocytes. Animals, 14.","DOI":"10.3390\/ani14071079"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/jgh.16723","article-title":"Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis","volume":"39","author":"Chee","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"28b","DOI":"10.1016\/S0002-9149(01)01454-0","article-title":"Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"87","author":"McTaggart","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1567-5688(03)00004-7","article-title":"Comparative pharmacology of rosuvastatin","volume":"4","author":"McTaggart","year":"2003","journal-title":"Atheroscler. Suppl."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2013.04.025","article-title":"Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders","volume":"711","author":"Mahalwar","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zhang, S., Ren, X., Zhang, B., Lan, T., and Liu, B. (2024). A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action. Molecules, 29.","DOI":"10.3390\/molecules29081859"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.03.004","article-title":"Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt\/Nrf2\/heme oxygenase-1 pathway","volume":"82","author":"Yeh","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ten\u00f3rio, M., Graciliano, N.G., Moura, F.A., Oliveira, A.C.M., and Goulart, M.O.F. (2021). N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants, 10.","DOI":"10.3390\/antiox10060967"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Dludla, P.V., Nkambule, B.B., Mazibuko-Mbeje, S.E., Nyambuya, T.M., Marcheggiani, F., Cirilli, I., Ziqubu, K., Shabalala, S.C., Johnson, R., and Louw, J. (2020). N-Acetyl Cysteine Targets Hepatic Lipid Accumulation to Curb Oxidative Stress and Inflammation in NAFLD: A Comprehensive Analysis of the Literature. Antioxidants, 9.","DOI":"10.3390\/antiox9121283"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Argaev-Frenkel, L., and Rosenzweig, T. (2022). Complexity of NAC Action as an Antidiabetic Agent: Opposing Effects of Oxidative and Reductive Stress on Insulin Secretion and Insulin Signaling. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23062965"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K., and Ramnarain, D. (2022). Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00980-1"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: A prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"hcaa052-010","DOI":"10.1093\/qjmed\/hcaa052.010","article-title":"Cytokeratin 18 as a non invasive marker in diagnosis of NASH and its usefulness in correlation with disease severity in Egyptian patients","volume":"113","author":"Maher","year":"2020","journal-title":"QJM Int. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.4254\/wjh.v13.i11.1688","article-title":"Abnormal liver enzymes: A review for clinicians","volume":"13","author":"Kalas","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Perumpail, B.J., Li, A.A., John, N., Sallam, S., Shah, N.D., Kwong, W., Cholankeril, G., Kim, D., and Ahmed, A. (2018). The Role of Vitamin E in the Treatment of NAFLD. Diseases, 6.","DOI":"10.3390\/diseases6040086"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.31351\/vol31iss2pp135-143","article-title":"Therapeutic Effects of Vitamin E in Non-alcoholic Fatty Liver Disease: An Open-Labeled Clinical Trial","volume":"31","year":"2022","journal-title":"Iraqi J. Pharm. Sci."},{"key":"ref_48","first-page":"12","article-title":"N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease","volume":"10","author":"Khoshbaten","year":"2010","journal-title":"Hepat. Mon."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-020-01274-y","article-title":"Long term N-acetylcysteine administration rescues liver steatosis via endoplasmic reticulum stress with unfolded protein response in mice","volume":"19","author":"Tsai","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.3748\/wjg.v21.i25.7860","article-title":"Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome","volume":"21","author":"Kargiotis","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/hepr.12821","article-title":"Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice","volume":"47","author":"Marinho","year":"2017","journal-title":"Hepatol. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1445-5994.2006.01295.x","article-title":"Effects of vitamin E treatment on peroxisome proliferator-activated receptor-\u03b1 expression and insulin resistance in patients with non-alcoholic steatohepatitis: Results of a pilot study","volume":"37","author":"Yakaryilmaz","year":"2007","journal-title":"Intern. Med. J."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Cheng, J., Joyce, A., Yates, K., Aouizerat, B., and Sanyal, A.J. (2012). Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH). PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044106"},{"key":"ref_54","first-page":"553","article-title":"S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis","volume":"7","author":"Mazo","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11894-017-0584-7","article-title":"Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects","volume":"19","author":"Vargas","year":"2017","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Zheng, S.-H., Chen, X.-X., Chen, Y., Wu, Z.-C., Chen, X.-Q., and Li, X.-L. (2023). Antioxidant vitamins supplementation reduce endometriosis related pelvic pain in humans: A systematic review and meta-analysis. Reprod. Biol. Endocrinol., 21.","DOI":"10.1186\/s12958-023-01126-1"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Mlejnek, P., Dolezel, P., Kriegova, E., and Pastvova, N. (2021). N-acetylcysteine Can Induce Massive Oxidative Stress, Resulting in Cell Death with Apoptotic Features in Human Leukemia Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312635"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2527\/jas.2013-6755","article-title":"Regulation of N-acetyl cysteine on gut redox status and major microbiota in weaned piglets","volume":"92","author":"Xu","year":"2014","journal-title":"J. Anim. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","article-title":"The chemistry and biological activities of N-acetylcysteine","volume":"1830","author":"Samuni","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_60","first-page":"11","article-title":"A review on various uses of N-acetyl cysteine","volume":"19","author":"Mokhtari","year":"2017","journal-title":"Cell J."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Mansouri, A., Reiner, \u017d., Ruscica, M., Tedeschi-Reiner, E., Radbakhsh, S., Bagheri Ekta, M., and Sahebkar, A. (2022). Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2\/HO-1 Signaling in Different Diseases. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051313"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2012.12.014","article-title":"Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance","volume":"57","author":"Niture","year":"2013","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3214196","DOI":"10.1155\/2019\/3214196","article-title":"New insights into the Nrf-2\/HO-1 signaling axis and its application in pediatric respiratory diseases","volume":"2019","author":"Zhang","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.fct.2018.07.024","article-title":"The role of nuclear factor erythroid 2-related factor 2 in hepatoprotective activity of natural products: A review","volume":"120","author":"Iranshahy","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"ref_65","first-page":"1757","article-title":"Effects of n-acetyl-cysteine supplementation in late gestational diet on maternal-placental redox status, placental NLRP3 inflammasome, and fecal microbiota in sows","volume":"97","author":"Luo","year":"2019","journal-title":"J. Anim. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/1753425914566205","article-title":"The anti-inflammatory effects of acetaminophen and N-acetylcysteine through suppression of the NLRP3 inflammasome pathway in LPS-challenged piglet mononuclear phagocytes","volume":"21","author":"Liu","year":"2015","journal-title":"Innate Immunity"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3790721","DOI":"10.1155\/2022\/3790721","article-title":"The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications","volume":"2022","author":"Ding","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"30269","DOI":"10.3390\/ijms161226225","article-title":"Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine","volume":"16","author":"Moura","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6229460","DOI":"10.1155\/2021\/6229460","article-title":"The Role of Mesenchymal Stem Cells with Ascorbic Acid and N-Acetylcysteine on TNF-\u03b1, IL 1\u03b2, and NF-\u03ba\u03b2 Expressions in Acute Pancreatitis in Albino Rats","volume":"2021","author":"Abdelhafez","year":"2021","journal-title":"J. Diabetes Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e131530","DOI":"10.1172\/jci.insight.131530","article-title":"Effects of rosuvastatin on the immune system in healthy volunteers with normal serum cholesterol","volume":"4","author":"Karmaus","year":"2019","journal-title":"JCI Insight"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Chen, W., Deng, Z., Zhu, J., Yuan, L., Li, S., Zhang, Y., Wu, J., Huang, Z., Qin, T., and Ye, W. (2023). Rosuvastatin suppresses TNF-\u03b1-induced matrix catabolism, pyroptosis and senescence via the HMGB1\/NF-\u03baB signaling pathway in nucleus pulposus cells: Role of rosuvastatin in alleviating intervertebral disc degeneration. Acta Biochim. Biophys. Sin., 55.","DOI":"10.3724\/abbs.2023026"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ymgme.2021.01.005","article-title":"TRMU deficiency: A broad clinical spectrum responsive to cysteine supplementation","volume":"132","author":"Murali","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbrc.2007.09.018","article-title":"Thiol supplementation inhibits metalloproteinase activity independent of glutathione status","volume":"363","author":"Bogani","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Crinelli, R., Zara, C., Galluzzi, L., Buffi, G., Ceccarini, C., Smietana, M., Mari, M., Magnani, M., and Fraternale, A. (2021). Activation of NRF2 and ATF4 Signaling by the Pro-Glutathione Molecule I-152, a Co-Drug of N-Acetyl-Cysteine and Cysteamine. Antioxidants, 10.","DOI":"10.3390\/antiox10020175"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1515\/tjb-2017-0046","article-title":"Effects of calcium hydroxide and N-acetylcysteine on MMP-2, MMP-9, TIMP-1 and TIMP-2 in LPS-stimulated macrophage cell lines","volume":"43","author":"Aksoy","year":"2018","journal-title":"Turk. J. Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"113914","DOI":"10.1016\/j.ecoenv.2022.113914","article-title":"Combined intervention with N-acetylcysteine and desipramine alleviated silicosis development by regulating the Nrf2\/HO-1 and ASMase\/ceramide signaling pathways","volume":"242","author":"Tang","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2008.02.012","article-title":"Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis","volume":"49","author":"Yang","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00204-007-0192-7","article-title":"Arsenite induced oxidative damage in mouse liver is associated with increased cytokeratin 18 expression","volume":"81","author":"Gonsebatt","year":"2007","journal-title":"Arch. Toxicol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3320325","DOI":"10.1155\/2021\/3320325","article-title":"Drug-induced liver injury: Clinical evidence of N-acetyl cysteine protective effects","volume":"2021","author":"Ntamo","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00432-011-1041-x","article-title":"Redox regulation of cytokeratin 18 protein by NADPH oxidase 1 in preneoplastic human epithelial cells","volume":"137","author":"Sattayakhom","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_81","first-page":"50","article-title":"Dynamics of IL-6 and CK-18 Concentration in Blood Plasma in Patients with Familial hypercholesterinemia with Non-Alcoholic Steatohepatitis Against the Background of Statin Therapy and Hepatoprotector","volume":"2","author":"Aleksandrovich","year":"2018","journal-title":"Therapy"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"76","DOI":"10.26724\/2079-8334-2022-3-81-76-82","article-title":"Quercetin effectiveness in the complex hypolipidemic therapy of patients with nonalcoholic fatty liver disease with metabolic syndrome","volume":"82","author":"Kravchenko","year":"2022","journal-title":"World Med. Biol."},{"key":"ref_83","first-page":"432","article-title":"The effects of N-acetylcysteine on hepatic, hematologic, and renal parameters in cirrhotic patients: A randomized controlled trial","volume":"16","author":"Hatami","year":"2023","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"100343","DOI":"10.1016\/j.phanu.2023.100343","article-title":"The efficacy of N-acetylcysteine in improving liver function: A systematic review and meta-analysis of controlled clinical trials","volume":"24","author":"Adeli","year":"2023","journal-title":"PharmaNutrition"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Sohouli, M.H., Eslamian, G., Malekpour Alamdari, N., Abbasi, M., Fazeli Taherian, S., Behtaj, D., and Zand, H. (2023). Effects of N-acetylcysteine on aging cell and obesity complications in obese adults: A randomized, double-blind clinical trial. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1237869"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Liu, J., Su, H., Jin, X., Wang, L., and Huang, J. (2023). The effects of N-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: A systematic review and meta-analysis. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1209614"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"9949453","DOI":"10.1155\/2021\/9949453","article-title":"N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks)","volume":"2021","author":"Schwalfenberg","year":"2021","journal-title":"J. Nutr. Metab."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Mostaza, J.M., and Escobar, C. (2024). Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk. J. Clin. Med., 13.","DOI":"10.3390\/jcm13071894"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/JCMA.0000000000001114","article-title":"The effect of statin treatment on glucose homeostasis in prediabetic individuals: A prospective, randomized, controlled trial","volume":"87","author":"Cheng","year":"2024","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1592\/phco.24.6.584.34738","article-title":"Statins and liver toxicity: A meta-analysis","volume":"24","author":"Spinler","year":"2004","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3748\/wjg.v13.i8.1286","article-title":"Liver toxicity of rosuvastatin therapy","volume":"13","author":"Famularo","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Chin, R., and Lee, B.Y. (2008). Chapter 16\u2013Data Interpretation and Conclusions. Principles and Practice of Clinical Trial Medicine, Academic Press.","DOI":"10.1016\/B978-0-12-373695-6.00016-8"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.4103\/sja.SJA_559_18","article-title":"The CONSORT statement","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J. Anaesth."},{"key":"ref_95","first-page":"357","article-title":"Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic","volume":"15","author":"Pandyarajan","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3945\/ajcn.2008.26698","article-title":"Estimates of excess deaths associated with body mass index and other anthropometric variables","volume":"89","author":"Flegal","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1047-2797(03)00067-X","article-title":"Waist to stature ratio is more strongly associated with cardiovascular risk factors than other simple anthropometric indices","volume":"13","author":"Ho","year":"2003","journal-title":"Ann. Epidemiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/archdischild-2015-309645","article-title":"Anthropometric measures are simple and accurate paediatric weight-prediction proxies in resource-poor settings with a high HIV prevalence","volume":"102","author":"Whitfield","year":"2017","journal-title":"Arch. Dis. Child."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/jamainternmed.2015.2405","article-title":"Prevalence of overweight and obesity in the United States, 2007\u20132012","volume":"175","author":"Yang","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Ali, A.H., Al Juboori, A., Petroski, G.F., Diaz-Arias, A.A., Syed-Abdul, M.M., Wheeler, A.A., Ganga, R.R., Pitt, J.B., Spencer, N.M., and Hammoud, G.M. (2022). The Utility and Diagnostic Accuracy of Transient Elastography in Adults with Morbid Obesity: A Prospective Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051201"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jceh.2021.06.008","article-title":"FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis\u2013Validation in an Indian Cohort","volume":"12","author":"De","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"John, K., Franck, M., Al Aoua, S., Rau, M., Huber, Y., Schattenberg, J.M., Geier, A., Bahr, M.J., Wedemeyer, H., and Schulze-Osthoff, K. (2022). Non-invasive detection of fibrotic NASH in NAFLD patients with low or intermediate FIB-4. J. Clin. Med., 11.","DOI":"10.3390\/jcm11154394"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.cgh.2022.03.044","article-title":"Development and validation of a score for fibrotic nonalcoholic steatohepatitis","volume":"21","author":"Tavaglione","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/apt.14621","article-title":"Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH","volume":"47","author":"Boursier","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.17352\/2455-5282.000155","article-title":"Evaluation of the effect of total saponins and tannins isolated from Dialium guineense stem bark on CCl4-Induced hepatotoxicity in wistar rats","volume":"9","author":"Abu","year":"2022","journal-title":"Glob. J. Med. Clin. Case Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1159\/000459586","article-title":"Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine","volume":"12","author":"Belfield","year":"1971","journal-title":"Enzyme"},{"key":"ref_107","first-page":"e22959","article-title":"Evaluation of Homocysteine and Gamma-Glutamyl Transferase Concentrations As Markers of Chronic Kidney Disease: An Indian Perspective","volume":"14","author":"Shyamkrishnan","year":"2022","journal-title":"Cureus"},{"key":"ref_108","first-page":"115","article-title":"Metformin ameliorates oxidative stress induced by diabetes mellitus and hepatocellular carcinoma in rats","volume":"9","year":"2020","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/clinchem\/26.5.555","article-title":"Kinetic serum creatinine assays. II. A critical evaluation and review","volume":"26","author":"Bowers","year":"1980","journal-title":"Clin. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF01484513","article-title":"Enzymatic urea determination in the blood and serum in the Warburg optical test","volume":"43","author":"Talke","year":"1965","journal-title":"Klin. Wochenschr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/clinchem\/18.8.829","article-title":"Enzymatic kinetic rate and end-point analyses of substrate, by use of a GeMSAEC fast analyzer","volume":"18","author":"Tiffany","year":"1972","journal-title":"Clin. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/clinchem\/26.2.227","article-title":"Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid\/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine","volume":"26","author":"Fossati","year":"1980","journal-title":"Clin. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM197902223000808","article-title":"Receptors, antireceptor antibodies and mechanisms of insulin resistance","volume":"300","author":"Flier","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0004-28032010000200009","article-title":"Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals","volume":"47","author":"Salgado","year":"2010","journal-title":"Arq. Gastroenterol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","article-title":"Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges","volume":"524","author":"Tsikas","year":"2017","journal-title":"Anal. Biochem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00210-020-01881-7","article-title":"Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: Modulation of the expression of TGF-\u03b21 and iNOS","volume":"393","author":"Gungor","year":"2020","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s43094-024-00593-6","article-title":"The possible anti-inflammatory effect of extra virgin olive oil with colchicine in treatment of resistant cases of familial Mediterranean fever in a cohort of pediatric Egyptian patients","volume":"10","author":"Osman","year":"2024","journal-title":"Future J. Pharm. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Monserrat-Mesquida, M., Quetglas-Llabr\u00e9s, M., Abbate, M., Montemayor, S., Mascar\u00f3, C.M., Casares, M., Tejada, S., Abete, I., Zulet, M.A., and Tur, J.A. (2020). Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease. Antioxidants, 9.","DOI":"10.3390\/antiox9080759"},{"key":"ref_120","first-page":"2546","article-title":"Correlation of CD3+\/CD4+, and serum CK-18 fragment levels with glucose and lipid metabolism in elderly type 2 diabetes patients with nonalcoholic fatty liver disease","volume":"13","author":"Zhao","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ejcdt.2014.06.014","article-title":"Study of the level of sputum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor metalloproteinase-1 (TIMP-1) in COPD patients","volume":"63","author":"Esa","year":"2014","journal-title":"Egypt. J. Chest Dis. Tuberc."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Barchetta, I., Del Ben, M., Angelico, F., Di Martino, M., Fraioli, A., La Torre, G., Saulle, R., Perri, L., Morini, S., and Tiberti, C. (2016). No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. BMC Med., 14.","DOI":"10.1186\/s12916-016-0638-y"},{"key":"ref_123","first-page":"1","article-title":"Health-related quality of life burden of nonalcoholic steatohepatitis: A robust pragmatic literature review","volume":"2","author":"Bae","year":"2018","journal-title":"J. Patient-Rep. Outcomes"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.cgh.2021.07.020","article-title":"Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_125","first-page":"Cd012419","article-title":"Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications","volume":"5","author":"Cross","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(04)00457-4","article-title":"A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","volume":"2","author":"Sanyal","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/5\/650\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:23:58Z","timestamp":1760030638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/5\/650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":126,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ph18050650"],"URL":"https:\/\/doi.org\/10.3390\/ph18050650","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}